Table 3 Respiratory support and associated outcomes before and after intervention.
Before Intervention | After Intervention | Odds ratios (95%CI), p-values | |
|---|---|---|---|
Overall sample | n = 335 | n = 396 | |
Respiratory support | |||
CPAP daysa | 10 (5–19) | 27 (10–39) | p < 0.0001 |
Oxygen daysa | 26 (4–70) | 15 (4–42) | p = 0.03 |
Mechanical ventilation daysa | 1 (0–5) | 0 (0–3) | <0.001 |
Non-invasive ventilation daysa | 0 (0–7) | 0 (0–7) | p = 0.53 |
Outcomes | |||
Survival without BPD | 199 (59.4) | 294 (74.2) | 1.86 (1.25–2.76), 0.01 |
Mortality < 36–week PMA | 35 (10) | 35 (9) | 1.47 (0.77–2.80), 0.24 |
BPD | 67 (25.2) | 22 (6.9) | 0.12 (0.06–0.26), <0.001 |
Infants 22–25 weeks | n = 92 | n = 89 | |
Respiratory support | |||
CPAP daysa | 18 (11–30) | 43 (33–50) | p < 0.0001 |
Oxygen daysa | 100 (77–120) | 76 (54–102) | p = 0.02 |
Mechanical ventilation daysa | 33 (18–52) | 25 (11–36) | 0.02 |
Non-invasive ventilation daysa | 28 (15–41) | 16 (6–25) | p = 0.007 |
Outcomes | |||
Survival without BPD | 13 (14) | 41 (46) | 6.44 (2.59–16.0), <0.001 |
Mortality ≤ 36–week PMA | 29 (32) | 21 (24) | 0.52 (0.16–1.71), 0.96 |
BPD | 37 (74) | 10 (19) | 0.02 (0.01–0.11), <0.001 |
Infants 26–29 weeks | n = 125 | n = 170 | |
Respiratory support | |||
CPAP daysa | 9 (4–16) | 28 (14–38) | p < 0.0001 |
Oxygen daysa | 19 (4–39) | 14 (4–29) | p = 0.17 |
Mechanical ventilation daysa | 1 (1–3) | 0 (0–2) | 0.001 |
Non-invasive ventilation daysa | 0 (0–5) | 0 (0–3) | p = 0.1 |
Outcomes | |||
Survival without BPD | 84 (67) | 128 (75) | 1.39 (0.71–2.73), 0.34 |
Mortality ≤ 36–week PMA | 5 (4) | 14 (8) | 3.19 (0.86–11.8), 0.08 |
BPD | 24 (22) | 11 (8) | 0.17 (0.05–0.53), 0.002 |
Infants 30–34 weeks | n = 118 | n = 137 | |
Respiratory support | |||
CPAP daysa | 5 (2–10) | 8 (4–12) | p = 0.26 |
Oxygen daysa | 2 (1–7) | 3 (2–6) | p = 0.76 |
Mechanical ventilation daysa | 0 (0–0) | 0 (0–0) | 0.004 |
Non-invasive ventilation daysa | 0 (0–0) | 0 (0–0) | p = 0.5 |
Outcomes | |||
Survival without BPD | 102 (86) | 125 (91) | 1.26 (0.49–3.22), 0.63 |
Mortality ≤ 36–week PMA | 1 (1) | 0 (0) | n/a |
BPD | 6 (5) | 1 (1) | 0.18 (0.02–1.83), 0.15 |